Kite Lake Capital Management (UK)’s NxStage Medical Inc. NXTM Stock Holding History

Kite Lake Capital Management (UK)’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-655,364	Closed	-$18.8M	–	16
2018 Q4	$18.8M	Buy	+655,364	New	+$18.6M	6%	7
2018 Q3	–	Sell	-350,932	Closed	-$9.79M	–	18
2018 Q2	$9.79M	Buy	350,932 +185,788	+113%	+$4.98M	3.4%	8
2018 Q1	$4.11M	Buy	165,144 +94,278	+133%	+$2.29M	0.66%	12
2017 Q4	$1.72M	Buy	+70,866	New	+$1.87M	0.2%	12

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Kite Lake Capital Management (UK)'s NXTM Position: Q1 2019 in Review

Kite Lake Capital Management (UK) sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 655,364 shares — an estimated $18.8M sold.

Kite Lake Capital Management (UK) first reported a position in NXTM in Q4 2017 and held it in 4 quarters. The position peaked at $18.8M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Kite Lake Capital Management (UK) reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Kite Lake Capital Management (UK) sold 655,364 NxStage Medical Inc. shares in Q1 2019, an estimated $18.8M.
Kite Lake Capital Management (UK) first reported a position in NxStage Medical Inc. in Q4 2017 and held it in 4 quarters.
Kite Lake Capital Management (UK)'s NxStage Medical Inc. position peaked at $18.8M in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Kite Lake Capital Management (UK)'s 13F filing for Q1 2019, filed 15 May 2019.